Xtent Inc (XTNT)

Ticker: XTNT


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
132.95
Quantity 58,340 -38.3%
Value US$4,407,364
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
357.14
Quantity 97,244 +21.1%
Value US$670,250
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
57.54
Quantity 81,563 -25.0%
Value US$1,672,569
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.38
Quantity 300 -0.4%
Value US$414
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.36
Quantity 100 -0.1%
Value US$136
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.35
Quantity 1,400 -1.9%
Value US$1,890
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.34
Quantity 500 -0.7%
Value US$670
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.33
Quantity 200 -0.3%
Value US$266
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.32
Quantity 300 -0.4%
Value US$396
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.31
Quantity 100 -0.1%
Value US$131
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.30
Quantity 800 -1.1%
Value US$1,040
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
1.25
Quantity 100 -0.1%
Value US$125
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.07
Quantity 100 -0.1%
Value US$207
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.05
Quantity 100 -0.1%
Value US$205
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.01
Quantity 350 -0.5%
Value US$704
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.00
Quantity 4,400 -5.5%
Value US$8,800
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.60
Quantity 1,000 -1.2%
Value US$2,600
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.57
Quantity 100 -0.1%
Value US$257
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.56
Quantity 100 -0.1%
Value US$256
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
2.55
Quantity 2,200 -2.6%
Value US$5,610
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.56
Quantity 500 -0.6%
Value US$1,780
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.52
Quantity 200 -0.2%
Value US$704
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.50
Quantity 200 -0.2%
Value US$700
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.45
Quantity 200 -0.2%
Value US$690
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.44
Quantity 100 -0.1%
Value US$344
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.43
Quantity 1,700 -1.9%
Value US$5,831
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
3.42
Quantity 200 -0.2%
Value US$684
Walsh Brian J VP-Sales & Marketing Officer
Transaction date
Planned sale
Price
4.00
Quantity 2,000 -4.3%
Value US$8,000
Walsh Brian J VP-Sales & Marketing Officer
Transaction date
Planned sale
Price
4.25
Quantity 1,000 -2.1%
Value US$4,250
Walsh Brian J VP-Sales & Marketing Officer
Transaction date
Planned sale
Price
4.48
Quantity 2,000 -4.1%
Value US$8,960
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
5.00
Quantity 1,200 -1.1%
Value US$6,000
Kahlenberg Timothy D Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.05
Quantity 798 -100.0%
Value US$4,030
Kahlenberg Timothy D Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.00
Quantity 202 -100.0%
Value US$1,010
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 1,198 -0.2%
Value US$5,990
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 300 -0.0%
Value US$2,055
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.86
Quantity 566 -0.1%
Value US$3,883
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.87
Quantity 201 -0.0%
Value US$1,381
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.90
Quantity 199 -0.0%
Value US$1,373
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.91
Quantity 33 -0.0%
Value US$228
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.94
Quantity 33 -0.0%
Value US$229
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.95
Quantity 66 -0.0%
Value US$459
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
6.98
Quantity 201 -0.0%
Value US$1,403
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
7.46
Quantity 201 -0.0%
Value US$1,499
Casciaro Gregory D President and CEO Executive Director
Transaction date
Planned sale
Price
7.50
Quantity 67 -0.0%
Value US$502
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.85
Quantity 300 -0.3%
Value US$2,055
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.86
Quantity 3,066 -2.6%
Value US$21,033
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.87
Quantity 700 -0.6%
Value US$4,809
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.90
Quantity 200 -0.2%
Value US$1,380
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.91
Quantity 34 -0.0%
Value US$235
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.94
Quantity 34 -0.0%
Value US$236
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.95
Quantity 67 -0.1%
Value US$466
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
6.98
Quantity 200 -0.2%
Value US$1,396
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
7.46
Quantity 200 -0.2%
Value US$1,492
Grainger Jeffry J VP-Corp Affairs & Gen. Counsel Officer
Transaction date
Planned sale
Price
7.50
Quantity 66 -0.1%
Value US$495
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.49
Quantity 100 -0.1%
Value US$749
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.30
Quantity 100 -0.1%
Value US$730
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.18
Quantity 100 -0.1%
Value US$718
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.16
Quantity 300 -0.3%
Value US$2,148
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.15
Quantity 200 -0.2%
Value US$1,430
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.14
Quantity 200 -0.2%
Value US$1,428
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.12
Quantity 200 -0.2%
Value US$1,424
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.11
Quantity 400 -0.4%
Value US$2,844
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.10
Quantity 100 -0.1%
Value US$710
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.07
Quantity 100 -0.1%
Value US$707
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.06
Quantity 100 -0.1%
Value US$706
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.01
Quantity 200 -0.2%
Value US$1,402
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
7.00
Quantity 300 -0.3%
Value US$2,100
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.95
Quantity 200 -0.2%
Value US$1,390
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.93
Quantity 100 -0.1%
Value US$693
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.89
Quantity 100 -0.1%
Value US$689
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.87
Quantity 100 -0.1%
Value US$687
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.86
Quantity 400 -0.4%
Value US$2,744
Marco Philippe H VP-QA, Clinical & Reg. Affairs Officer
Transaction date
Planned sale
Price
6.85
Quantity 100 -0.1%
Value US$685
Kahlenberg Timothy D Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.86
Quantity 68 -100.0%
Value US$466
Kahlenberg Timothy D Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.90
Quantity 201 -74.7%
Value US$1,387
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
58,340 -38.3%
132.95
US$4,407,364
58,340 -38.3% 132.95 US$4,407,364
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
97,244 +21.1%
357.14
US$670,250
97,244 +21.1% 357.14 US$670,250
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
81,563 -25.0%
57.54
US$1,672,569
81,563 -25.0% 57.54 US$1,672,569
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
300 -0.4%
1.38
US$414
300 -0.4% 1.38 US$414
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
1.36
US$136
100 -0.1% 1.36 US$136
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
1,400 -1.9%
1.35
US$1,890
1,400 -1.9% 1.35 US$1,890
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
500 -0.7%
1.34
US$670
500 -0.7% 1.34 US$670
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.3%
1.33
US$266
200 -0.3% 1.33 US$266
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
300 -0.4%
1.32
US$396
300 -0.4% 1.32 US$396
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
1.31
US$131
100 -0.1% 1.31 US$131
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
800 -1.1%
1.30
US$1,040
800 -1.1% 1.30 US$1,040
2008-10-01 2008-10-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
1.25
US$125
100 -0.1% 1.25 US$125
2008-09-02 2008-09-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
2.07
US$207
100 -0.1% 2.07 US$207
2008-09-02 2008-09-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
2.05
US$205
100 -0.1% 2.05 US$205
2008-09-02 2008-09-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
350 -0.5%
2.01
US$704
350 -0.5% 2.01 US$704
2008-09-02 2008-09-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
4,400 -5.5%
2.00
US$8,800
4,400 -5.5% 2.00 US$8,800
2008-08-04 2008-08-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
1,000 -1.2%
2.60
US$2,600
1,000 -1.2% 2.60 US$2,600
2008-08-04 2008-08-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
2.57
US$257
100 -0.1% 2.57 US$257
2008-08-04 2008-08-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
2.56
US$256
100 -0.1% 2.56 US$256
2008-08-04 2008-08-01 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
2,200 -2.6%
2.55
US$5,610
2,200 -2.6% 2.55 US$5,610
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
500 -0.6%
3.56
US$1,780
500 -0.6% 3.56 US$1,780
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
3.52
US$704
200 -0.2% 3.52 US$704
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
3.50
US$700
200 -0.2% 3.50 US$700
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
3.45
US$690
200 -0.2% 3.45 US$690
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
3.44
US$344
100 -0.1% 3.44 US$344
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
1,700 -1.9%
3.43
US$5,831
1,700 -1.9% 3.43 US$5,831
2008-06-03 2008-06-02 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
3.42
US$684
200 -0.2% 3.42 US$684
2008-04-24 2008-04-24 PlS Planned sale Walsh Brian J

VP-Sales & Marketing

Officer
2,000 -4.3%
4.00
US$8,000
2,000 -4.3% 4.00 US$8,000
2008-04-24 2008-04-24 PlS Planned sale Walsh Brian J

VP-Sales & Marketing

Officer
1,000 -2.1%
4.25
US$4,250
1,000 -2.1% 4.25 US$4,250
2008-04-24 2008-04-23 PlS Planned sale Walsh Brian J

VP-Sales & Marketing

Officer
2,000 -4.1%
4.48
US$8,960
2,000 -4.1% 4.48 US$8,960
2008-04-02 2008-04-01 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
1,200 -1.1%
5.00
US$6,000
1,200 -1.1% 5.00 US$6,000
2008-04-02 2008-04-01 PlS Planned sale Kahlenberg Timothy D

Chief Financial Officer

Officer
798 -100.0%
5.05
US$4,030
798 -100.0% 5.05 US$4,030
2008-04-02 2008-04-01 PlS Planned sale Kahlenberg Timothy D

Chief Financial Officer

Officer
202 -100.0%
5.00
US$1,010
202 -100.0% 5.00 US$1,010
2008-04-02 2008-04-01 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
1,198 -0.2%
5.00
US$5,990
1,198 -0.2% 5.00 US$5,990
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
300 -0.0%
6.85
US$2,055
300 -0.0% 6.85 US$2,055
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
566 -0.1%
6.86
US$3,883
566 -0.1% 6.86 US$3,883
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
201 -0.0%
6.87
US$1,381
201 -0.0% 6.87 US$1,381
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
199 -0.0%
6.90
US$1,373
199 -0.0% 6.90 US$1,373
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
33 -0.0%
6.91
US$228
33 -0.0% 6.91 US$228
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
33 -0.0%
6.94
US$229
33 -0.0% 6.94 US$229
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
66 -0.0%
6.95
US$459
66 -0.0% 6.95 US$459
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
201 -0.0%
6.98
US$1,403
201 -0.0% 6.98 US$1,403
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
201 -0.0%
7.46
US$1,499
201 -0.0% 7.46 US$1,499
2008-03-05 2008-03-03 PlS Planned sale Casciaro Gregory D

President and CEO

Executive Director
67 -0.0%
7.50
US$502
67 -0.0% 7.50 US$502
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
300 -0.3%
6.85
US$2,055
300 -0.3% 6.85 US$2,055
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
3,066 -2.6%
6.86
US$21,033
3,066 -2.6% 6.86 US$21,033
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
700 -0.6%
6.87
US$4,809
700 -0.6% 6.87 US$4,809
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
200 -0.2%
6.90
US$1,380
200 -0.2% 6.90 US$1,380
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
34 -0.0%
6.91
US$235
34 -0.0% 6.91 US$235
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
34 -0.0%
6.94
US$236
34 -0.0% 6.94 US$236
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
67 -0.1%
6.95
US$466
67 -0.1% 6.95 US$466
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
200 -0.2%
6.98
US$1,396
200 -0.2% 6.98 US$1,396
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
200 -0.2%
7.46
US$1,492
200 -0.2% 7.46 US$1,492
2008-03-04 2008-03-03 PlS Planned sale Grainger Jeffry J

VP-Corp Affairs & Gen. Counsel

Officer
66 -0.1%
7.50
US$495
66 -0.1% 7.50 US$495
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.49
US$749
100 -0.1% 7.49 US$749
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.30
US$730
100 -0.1% 7.30 US$730
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.18
US$718
100 -0.1% 7.18 US$718
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
300 -0.3%
7.16
US$2,148
300 -0.3% 7.16 US$2,148
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
7.15
US$1,430
200 -0.2% 7.15 US$1,430
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
7.14
US$1,428
200 -0.2% 7.14 US$1,428
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
7.12
US$1,424
200 -0.2% 7.12 US$1,424
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
400 -0.4%
7.11
US$2,844
400 -0.4% 7.11 US$2,844
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.10
US$710
100 -0.1% 7.10 US$710
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.07
US$707
100 -0.1% 7.07 US$707
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
7.06
US$706
100 -0.1% 7.06 US$706
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
7.01
US$1,402
200 -0.2% 7.01 US$1,402
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
300 -0.3%
7.00
US$2,100
300 -0.3% 7.00 US$2,100
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
200 -0.2%
6.95
US$1,390
200 -0.2% 6.95 US$1,390
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
6.93
US$693
100 -0.1% 6.93 US$693
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
6.89
US$689
100 -0.1% 6.89 US$689
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
6.87
US$687
100 -0.1% 6.87 US$687
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
400 -0.4%
6.86
US$2,744
400 -0.4% 6.86 US$2,744
2008-03-04 2008-03-03 PlS Planned sale Marco Philippe H

VP-QA, Clinical & Reg. Affairs

Officer
100 -0.1%
6.85
US$685
100 -0.1% 6.85 US$685
2008-03-04 2008-03-03 PlS Planned sale Kahlenberg Timothy D

Chief Financial Officer

Officer
68 -100.0%
6.86
US$466
68 -100.0% 6.86 US$466
2008-03-04 2008-03-03 PlS Planned sale Kahlenberg Timothy D

Chief Financial Officer

Officer
201 -74.7%
6.90
US$1,387
201 -74.7% 6.90 US$1,387
Explore more

More insider trading research around Xtent Inc